Gelatinous Marrow Transformation in Chronic Myeloid Leukemia Post-Dasatinib Treatment: A Case Report with Review of Literature
Gelatinous marrow transformation (GMT) is characterized by accumulation of extracellular gelatinous substances such as mucopolysaccharides, fat cell atrophy, and focal loss of hematopoietic cells. It is a rare disorder of unknown pathogenesis. Anorexia nervosa, acute febrile state, acquired immunode...
Saved in:
| Main Authors: | Gayathri Kini, Chandni Bhandary, Poornachandra Vivekananda, Chandrashekhar S. Jayaprakash |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809348 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01) -
Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia
by: Cheng F, et al.
Published: (2025-05-01) -
Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
by: TI Ionova, et al.
Published: (2017-04-01) -
Post-induction bone marrow uncovers mastocytosis in a case of acute myeloid leukemia-Case report
by: Tharageswari Srinivasan, et al.
Published: (2025-06-01) -
Chronic myeloid leukemia — before and after imatinib (Third part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)